Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 545

1.

Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.

Schneider JP.

Geriatrics. 2009 Jan;64(1):18-23.

PMID:
19256578
[PubMed - indexed for MEDLINE]
2.

Low-energy femoral shaft fractures associated with alendronate use.

Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG.

J Orthop Trauma. 2008 May-Jun;22(5):346-50. doi: 10.1097/BOT.0b013e318172841c.

PMID:
18448990
[PubMed - indexed for MEDLINE]
3.

Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.

Angthong C, Angthong W.

J Med Assoc Thai. 2011 Dec;94 Suppl 7:S214-20.

PMID:
22619933
[PubMed - indexed for MEDLINE]
4.

[New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].

Yamaguchi T, Sugimoto T.

Clin Calcium. 2009 Jan;19(1):38-43. doi: CliCa09013843. Review. Japanese.

PMID:
19122263
[PubMed - indexed for MEDLINE]
5.

Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.

Capeci CM, Tejwani NC.

J Bone Joint Surg Am. 2009 Nov;91(11):2556-61. doi: 10.2106/JBJS.H.01774.

PMID:
19884427
[PubMed - indexed for MEDLINE]
6.

Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.

Lee JK.

Int J Rheum Dis. 2009 Jul;12(2):149-54. doi: 10.1111/j.1756-185X.2009.01396.x.

PMID:
20374333
[PubMed - indexed for MEDLINE]
7.

Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.

Ng YH, Gino PD, Lingaraj K, Das De S.

Injury. 2011 Jul;42(7):702-6. doi: 10.1016/j.injury.2010.12.019. Epub 2011 Feb 11.

PMID:
21316051
[PubMed - indexed for MEDLINE]
8.

Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy.

Cermak K, Shumelinsky F, Alexiou J, Gebhart MJ.

Clin Orthop Relat Res. 2010 Jul;468(7):1991-6. doi: 10.1007/s11999-009-1192-0. Epub 2009 Dec 18.

PMID:
20020334
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Alendronate-associated femoral insufficiency fractures and femoral stress reactions.

Wang K, Moaveni A, Dowrick A, Liew S.

J Orthop Surg (Hong Kong). 2011 Apr;19(1):89-92.

PMID:
21519086
[PubMed - indexed for MEDLINE]
Free Article
10.

A rational approach to management of alendronate-related subtrochanteric fractures.

Das De S, Setiobudi T, Shen L, Das De S.

J Bone Joint Surg Br. 2010 May;92(5):679-86. doi: 10.1302/0301-620X.92B5.22941.

PMID:
20436006
[PubMed - indexed for MEDLINE]
11.

[Alendronate for treatment of osteoporoses].

Harada A.

Nihon Rinsho. 2009 May;67(5):943-7. Review. Japanese.

PMID:
19432114
[PubMed - indexed for MEDLINE]
12.

Risk of atypical femoral fracture with long-term use of alendronate (bisphosphonates) : a systemic review of literature.

Agarwal S, Agarwal S, Gupta P, Agarwal PK, Agarwal G, Bansal A.

Acta Orthop Belg. 2010 Oct;76(5):567-71. Review.

PMID:
21138208
[PubMed - indexed for MEDLINE]
13.

Spontaneous femoral shaft fracture after long-term alendronate.

Ali T, Jay RH.

Age Ageing. 2009 Sep;38(5):625-6. doi: 10.1093/ageing/afp106. Epub 2009 Jun 25.

PMID:
19556326
[PubMed - indexed for MEDLINE]
Free Article
14.

An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

Kwek EB, Goh SK, Koh JS, Png MA, Howe TS.

Injury. 2008 Feb;39(2):224-31. doi: 10.1016/j.injury.2007.08.036. Epub 2008 Jan 28.

PMID:
18222447
[PubMed - indexed for MEDLINE]
15.

Bilateral atypical femoral fractures after long-term alendronate therapy: a case report.

Bamrungsong T, Pongchaiyakul C.

J Med Assoc Thai. 2010 May;93(5):620-4.

PMID:
20524451
[PubMed - indexed for MEDLINE]
16.

Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.

Huang HT, Kang L, Huang PJ, Fu YC, Lin SY, Hsieh CH, Chen JC, Cheng YM, Chen CH.

Menopause. 2012 Dec;19(12):1360-3. doi: 10.1097/gme.0b013e318260143d.

PMID:
22968250
[PubMed - indexed for MEDLINE]
17.

A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.

Cross MB, Nam D, van der Meulen MC, Bostrom MP.

J Bone Joint Surg Br. 2012 Jul;94(7):994-7. doi: 10.1302/0301-620X.94B7.28778.

PMID:
22733959
[PubMed - indexed for MEDLINE]
18.

Case reports: two femoral insufficiency fractures after long-term alendronate therapy.

Sayed-Noor AS, Sjödén GO.

Clin Orthop Relat Res. 2009 Jul;467(7):1921-6. doi: 10.1007/s11999-009-0725-x. Epub 2009 Feb 6.

PMID:
19198962
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Unusual mid-shaft fractures during long-term bisphosphonate therapy.

Odvina CV, Levy S, Rao S, Zerwekh JE, Rao DS.

Clin Endocrinol (Oxf). 2010 Feb;72(2):161-8. doi: 10.1111/j.1365-2265.2009.03581.x. Epub 2009 Mar 19.

PMID:
19302584
[PubMed - indexed for MEDLINE]
20.

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.

Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC; Fracture Intervention Trial Steering Committee; HORIZON Pivotal Fracture Trial Steering Committee.

N Engl J Med. 2010 May 13;362(19):1761-71. doi: 10.1056/NEJMoa1001086. Epub 2010 Mar 24.

PMID:
20335571
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk